• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[阿洛西林在危急状况下的药代动力学:与解剖生理和病理因素相关的个体化给药方案]

[Pharmacokinetics of azlocillin in critical conditions: an individualized schedule of drug administration in relation to anatomo-physiologic and pathologic factors].

作者信息

Firsov A A, Nasonov V N, Mura'veva S A, Kruglov A A

出版信息

Antibiot Khimioter. 1989 Aug;34(8):620-4.

PMID:2589904
Abstract

Azlocillin pharmacokinetics was studied after a single intravenous injection of the antibiotic in a dose of 4 g in 20 patients in critical state. To elucidate the causes of significant individual variability of the antibiotic pharmacokinetics observed in the patients, multiple correlation analysis of the main pharmacokinetic parameters i. e. the area under the concentration/time curve, total clearance, steady-state volume of distribution and mean residence time was performed in regard to the "patient factors" such as sex, age, the volumes of transfused liquid, blood, plasma and blood substitutes, hemoglobin levels, erythrocyte count and ESR. Adequate correspondence of the predicted by the "patient factor" values of the areas under the concentration/time curve and the total clearance to the actually determined values was observed. Correspondence of the predicted values to the steady-state volume of distribution and the mean residence time to the actually determined values was satisfactory. A procedure for design of azlocillin individual dosage regimens based on calculating individual clearance by the "patient factors" is described.

摘要

对20例危重症患者单次静脉注射4g阿洛西林后,研究了其药代动力学。为阐明患者中观察到的抗生素药代动力学显著个体差异的原因,针对性别、年龄、输液量、输血量、血浆量、血液代用品量、血红蛋白水平、红细胞计数和血沉等“患者因素”,对主要药代动力学参数,即浓度/时间曲线下面积、总清除率、稳态分布容积和平均驻留时间进行了多重相关分析。观察到由“患者因素”预测的浓度/时间曲线下面积和总清除率值与实际测定值有充分的对应关系。预测值与稳态分布容积以及平均驻留时间与实际测定值的对应关系令人满意。描述了一种基于“患者因素”计算个体清除率来设计阿洛西林个体化给药方案的方法。

相似文献

1
[Pharmacokinetics of azlocillin in critical conditions: an individualized schedule of drug administration in relation to anatomo-physiologic and pathologic factors].[阿洛西林在危急状况下的药代动力学:与解剖生理和病理因素相关的个体化给药方案]
Antibiot Khimioter. 1989 Aug;34(8):620-4.
2
[The pharmacokinetics of azlocillin after single and multiple intravenous injections during the third trimester].[孕晚期单次及多次静脉注射阿洛西林后的药代动力学]
Zentralbl Gynakol. 1988;110(15):944-8.
3
[Azlocillin pharmacokinetics].[阿洛西林的药代动力学]
Antibiot Khimioter. 1988 Feb;33(2):138-41.
4
[Pharmacokinetic studies of azlocillin in pregnancy].阿洛西林在妊娠期的药代动力学研究
Z Geburtshilfe Perinatol. 1985 Mar-Apr;189(2):88-90.
5
[Individual schedule of administration of aminoglycosides with reference to anatomo-physiological and pathological factors].[关于氨基糖苷类药物给药的个体化方案:参考解剖生理学和病理因素]
Antibiot Khimioter. 1989 Sep;34(9):687-91.
6
Pharmacokinetic comparison of 5 g of azlocillin every 8 h and 4 g every 6 h in healthy volunteers.健康志愿者中每8小时静脉滴注5克阿洛西林与每6小时静脉滴注4克阿洛西林的药代动力学比较。
Antimicrob Agents Chemother. 1989 May;33(5):710-3. doi: 10.1128/AAC.33.5.710.
7
[The effect of continuous arteriovenous hemofiltration on the pharmacokinetics of azlocillin in anuric patients].[持续动静脉血液滤过对无尿患者阿洛西林药代动力学的影响]
Anaesthesist. 1990 May;39(5):275-8.
8
Concentration of azlocillin in human chondral tissue.阿洛西林在人软骨组织中的浓度。
Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Mar;267(4):537-40. doi: 10.1016/s0176-6724(88)80037-3.
9
[Azlocillin in the treatment of pulmonary infections in patients with cystic fibrosis: plasma concentrations and therapeutic indications].[阿洛西林治疗囊性纤维化患者肺部感染:血浆浓度及治疗指征]
Pediatr Med Chir. 1989 Jul-Aug;11(4):389-91.
10
Pharmacokinetics of azlocillin in children with and without cystic fibrosis treated for infectious diseases.
Methods Find Exp Clin Pharmacol. 1986 Dec;8(12):727-9.